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ABSTRACT

Pantothenate-p-nitroanilide

as a Substrate

for Pantetheinase Assay

by

Robert T. Davidson, Master of Science
Utah State University, 1994

Major Professor: Dr. Bonita W. Wyse
Department: Nutrition and Food Sciences

Pantothenate-p-nitroanilide

has been synthesized

a substrate in a continuous spectrophotometric

for use as

assay of

pantetheinase activity monitoring absorbance at 41 0 nm.
Pantothenate-p-nitroanilide

is a crystalline

compound with a

molecular weight of 338.0 and a melting point of 146-149°C. Use
of this substrate in the described assay is suitable for enzyme
activity determination

in high protein content media such as blood

serum. Serum pantetheinase activity was determined for rats of
varying pantothenate

nutriture.

Rats with mildly (but significantly,

p<0.05) lower serum pantothenate

levels had significantly

higher

viii
serum pantetheinase activities than the control group (6.24
nmol/min/ml

± 0.72 and 16. 16 nmol/min/ml ± 4. 14, respectively,

p=0.0005).
(79 pages)

INTRODUCTION

Pantetheinase is an amidase which converts one of the
vitamin pantothenate's

derivatives, namely pantetheine, back into

pantothenate with cysteamine as a coproduct (Fig. 1).
There have been numerous methods utilizing various
techniques devised to assay the activity of this enzyme, and they
are mentioned briefly as follows: i) measurement of oxygen uptake
by means of amine oxidase coupling ( 1), ii) chromatographic
separation of 14C-labeled substrate and product (2,3),
electrophoretic

iii)

separation of 14C-labeled substrate and product

(4) , iv) microbial assay of pantothenate

(5), v) pH-stat titration

products (6), vi) amino acid analysis of the N-ethylmaleimide
adduct of cysteamine (7), and vii) radioimmunoassay of
pantothenate product (3). These methods are all quite time
consuming and/or require specialized equipment.
With the exception of the assays using radiolabeled
substrate, these previously mentioned assays are also prone to
give high apparent activities if used to measure activity in a

of

0
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Figure 1. Enzymatic hydrolysis of pantetheine by pantetheinase results in the
products pantothenate and cysteamine.

N

3
medium, such as blood serum, containing no endogenous substrate
but which may contain endogenous levels of enzymatic reaction
product. This problem may be overcome by running an assay blank
for each sample. This can be done by assaying endogenous product
level before adding substrate and subtracting that from the value
obtained from assay with substrate added. However, high blank
values tax the limits of sensitivity on equipment, and small
enzyme activities might not be seen.
Despite the fact that neither pantetheine nor its enzymatic
hydrolysis products absorb light in the visible or ultraviolet
regions, there are three spectrophotometric

light

continuous absorbance

assays that are much easier and faster than the previously
mentioned assays. They are i) cysteamine is measured by the
absorbance of its fluoropyruvate adduct at 300 nm (3); ii)
mercaptide ion is monitored at 240 nm as its concentration
increases proportionately

with enzymatic hydrolysis (3); and iii)

S-pantetheine-3-pyruvate

(pantetheine-S-pyruvate)

forms a cyclic

compound upon enzymatic hydrolysis, which is monitored as it
absorbs strongly at 296 nm (8). Even though these three

4
spectrophotometric

assays provide advantages such as decreased

assay times, less specialized equipment, and no radiolabeled
compounds, none are suitable for measurement of enzyme activity
in high protein content media such as blood serum.
Because the spectrophotometric

continuous absorbance

assays are so simple and fast, and because protein in media such as
blood serum has a high absorbance near 280 nm, it would be
extremely convenient and advantageous to be able to use a simple
spectrophotometric

assay for pantetheinase that uses a substrate

which, upon enzymatic hydrolysis, would absorb light in a region of
the spectra in which protein has little or no absorbance.
It was the purpose of this study to synthesize and test a
substrate which, upon enzymatic hydrolysis in a
spectrophotometric

assay, absorbs light at a wavelength such that

there is minimal interference
blood serum).

from protein-containing

media ( e.g.
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Pantothenic Acid

History
Pantothenic acid is a water-soluble

vitamin that was first

identified as a growth factor and isolated from yeast in 19 3 3 by
Williams (9). This growth factor for yeast was extracted from a
variety of biological materials and consequently was called
"pantothenic" acid, derived from the Greek word pantos, meaning
"from everywhere." After both a chick "antidermatitis

factor"

( 10, 11) and a rat "liver filtrate factor" ( 12) were identified as
pantothenic acid, inclusion of this compound as a vitamin was
warranted because of its importance in animal nutrition.
soon led to its isolation and identification

Studies

of its chemical

structure as well as its synthesis (13).

Physiological Forms and
Biochemical Functions
Pantothenic acid is the metabolic precursor of several
coenzymes ( see Fig. 2) and, as such, functions widely as a mediator
in the metabolism of energy, carbohydrates, lipids, and amino acids
and acts specifically as a carrier of acyl groups. Abiko ( 5) and
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and degradative pathways of coenzyme A.

O')

7
Plesofsky-Vig

and Brambl ( 14) have identified more than 100

intermediary metabolic reactions involving two pantothenatederived coenzymes, namely coenzyme A and phosphopantetheine. As
an example of an intermediary reaction in the Krebs cycle,
coenzyme A (CoA) functions as an acyl acceptor for the pyruvate
and a-ketoglutarate

dehydrogenase complexes, forming acetyl-CoA

and succinyl-CoA, respectively. Pantothenic acid coenzymes
participate in fatty acid synthesis and degradation by carrying the
acids as acyl groups through repetiti'-'.'e synthetic or degradative
cycles.
Coenzyme A. In 1945, Lipmann (1 S) reported the acetylation
of sulfanilamide was dependent upon an enzyme-coenzyme system
present in liver homogenates. This coenzyme of acetylation, termed
"coenzyme A," was found to be a derivative of pantothenate by
Lipmann and co-workers in 1947 ( 16) and was also found to be
widely distributed throughout the body ( 17). Coenzyme A structure
was eventually enzymatically determined ( 18) and chemically
synthesized ( 19).
Pantetheine and pantethine. Both pantetheine and pantethine

8
were originally identified as a single growth factor for
Lactobacillus

bulgaricus in 1949 (20) and shown to be a breakdown

product of coenzyme A with a content of 65-75% pantothenate by
weight ( 21 ) . Structural determination and synthesis were
accomplished the same year (22). The names "pantetheine" and
"pantethine" were proposed for the growth factor's sulfhydral and
disulfide forms, respectively,

indicating their relationship to

pantothenic acid. Majerus et al. (23) later identified 4'phosphopantetheine as the prosthetic group in the acyl carrier
protein of fatty acid synthesis.
The structures of coenzyme A, pantothenate, and related
compounds are shown in Fig. 3. Alternative names of selected
compounds are given in Table 1.

Biological Relevance

Despite its importance and requirement to the human body,
the vitamin pantothenate has no recommended dietary or daily
allowance established by either the National Research Council's
Food and Nutrition Board or the United States Government's Food

9

t
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Figure 3. Structures and names of coenzyme A fragments.
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Table 1. Synonyms for selected compounds
in pantothenate metabolism
Pantothenic Acid*
( R)-N-( 2, 4-d ihydroxy-3,
D ( +) - N -(2 ,4-dihydroxy-3,

3-di methyl-1 -oxy butyl )-B-a la nine**
3-dimethylbutyryl)-B-alanine

chick antidermatitis factor
vitamin 8 3
Vitamin 8 5
Pantetheine
N-( pa ntothenyl )-13-aminoethanethiol
2, 4-dihydroxy-N-[3-[
( 2-mercaptoethyl) amino ]-3-oxopropyl]3 ,3-dimethylbutanamide*
2, 4-dihydroxy-N-[2-[
( 2-me rcaptoethyl)carbamoyl ]ethyl ]-3, 3d imethyl butyra mide **
a, y-d ihydroxy-B, 13-dimethylbutyryl-13-a la ny l-13-aminoethanethiol
Pantethine (the disulfide of pantetheine)
bis( N-pa ntothe noyl-13-aminoethyl )disulfide
N,N'-[dithiobis[2, 1-ethanediylimino(3-oxo-3,
1 -propanediyl]]bis-(2,4dihydroxy-3, 3-dimethylbutanamide ]*
N,N' -[ dithiobis( ethyleneiminocarbonylethylene)]
bis( 2, 4-di hydroxy-3, 3dimethylbutyramide )**
Lactobacillus bulgaricus factor (L8F)
Pantosin
Cysteamine
2-aminoethanethiol*
**
mercaptamine
B-mercaptoethylamine
2-aminoethyl mercaptan
thioethanolamine
decarboxycysteine
MEA
8ecaptan
Cystamine (the disulfide of cysteamine)
2,2'-dithiobisethylamine*
2,2'-dithiobisethanamine**
t3,t3'-diaminodiethyl disulfide
bis[j3-aminoethyl]disulfide
decarboxycystine
*Nomenclature used in Chemical Abstracts through the Eighth Collective Index,
1967-1971.
**Nomenclature used in Chemical Abstracts since the Eighth Collective
Index,1972-to date.
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and Drug Administration (24 ). Consequently, these groups have
alternatively

published intake values deemed "safe and adequate"

for normal, healthy individuals. The fact that there is no
recommendation may not be of great concern as the diet seems to
supply all the needed pantothenate, and deficiency symptoms in
humans have only been noted in cases where an antagonist was
introduced or in total parenteral nutrition (TPN) diets from which
pantothenate has been mistakenly omitted.
For a recommended dietary allowance to be established for
any nutrient, information pertaining to body pools as well as tissue
status and nutrient requirement should be known. Except for blood
serum, which contains only free pantothenate (25), pantothenic
acid status in the body has been traditionally difficult to
determine because of the several moieties into which pantothenate
is converted (see Figures 2 & 3 ) . In order to determine total
pantothenate status, it is necessary to liberate pantothenate from
these bound forms by enzymatic means (26). As can be seen in Fig.
2, there are three specific enzyme activities required to release
pantothenate from coenzyme A and the other intermediaries:

12
pyrophosphatase, orthophosphatase, and an amidase, pantetheinase.
The first two enzymes are available commercially in the form of
calf intestinal alkaline phosphatase, but the third enzyme, the
amidase, is not commercially available. It was the lack of a
suitably pure amidase preparation that caused the American
Association of Agricultural

Chemists to abandon its four-year

study to develop a standard assay for total pantothenate, stating:
Results using pigeon liver or hog kidney enzyme
preparations were similar. However, a loss of
activity of these enzyme preparations showed a
need for establishing the activity of the enzymes
before they could be relied upon for use in the assay
procedure.(Toepfer, p. 29) (27)
The report concluded that "when sufficient information on the
specific enzyme activity

[pantetheinase]

is available, it may be

desirable to reactivate collaborative studies" (p. 29). Consequently,
the amidase activities

used in various preparations for total

pantetheinase activity determination
comparisons between different
practically

were not quantified and

preparations and laboratories were

impossible to make until a suitable amidase

preparation procedure was developed.
It should be noted that the three-enzyme system of

13

pantothenate

liberation is designed to liberate pantothenate from

coenzyme A, and use of this system in tissue determinations is an
extrapolation of the assumption that bound pantothenate is present
in the tissues as coenzyme A or other bound forms of the vitamin
that are liberated by this three-enzyme system. This assumption is
not entirely correct. Majerus et al. (23) reported that in the acyl
carrier protein of fatty acid synthesis, phosphopantetheine

is

linked to serine via a phosphodiester bond that is not hydrolyzed by
the dual (phosphatase and amidase) enzyme treatment.

Likewise,

lmamoto et al. (28) reported that pantothenate may be bound in
other forms such as various natural glycosyl derivatives. However,
while the three-enzyme treatment

method may give lower total

pantothenate values than other methods (29), much valuable
information can be obtained concerning pantothenate body pools
using this current three-enzyme approach.
In 1982, Wittwer et al. (3,37) published a procedure for
sufficiently
pantothenate

purifying the amidase from pig kidney for use in
determinations. The amidase was called

pantetheinase because of its affinity for pantetheine as a

14
substrate.

Whole blood pantothenate status has been determined

using this three-enzyme

process (25,30,31)

coupled with

radioimmunoassay. Dupre et al. (32) have also reported purifying
the amidase to a lesser extent from horse kidney.
In the search for a suitably pure amidase preparation, there
have been numerous assays developed to measure pantetheinase
activity. These assays have been based on: oxygen uptake by means
of amine oxidase coupling ( 1), chromatographic
labeled substrate and product (2), electrophoretic

separation of 14Cseparation of

14C-labeled substrate and product ( 4 ), microbiological
pantothenate (S), pH-stat titration
analysis of the N-ethylmaleimide
radioimmunoassay of pantothenate

assay of

of products (6), amino acid
adduct of cysteamine (7),
product ( 3), and chromato-

graphic separation of 14C-labeled pantethine and product (3 ).
There are also the previously mentioned three simple
spectrophotometric

absorbance assays, two of which are

continuous assays and are described in detail in the "Methods"
section and all three described briefly here as follows: i)
cysteamine is measured by the absorbance of its fluoropyruvate

15

adduct at 300 nm (3); ii) mercaptide ion is monitored at 240 nm as
its concentration

increases proportionately

with enzymatic

hydrolysis (3 ); and iii) the use of the substrate S-pantetheine-3pyruvate (pantetheine-S-pyruvate),

which forms a chromogenic,

cyclic compound upon enzymatic hydrolysis, absorbing strongly at
296 nm (8).
While these three assays provide many advantages over other
assays of pantetheinase activity,
ultraviolet

they utilize wavelengths in the

range where absorbing interference

from proteins is

also encountered. In countering protein absorbance effects,
sensitivity

limitations

of these assays are usually exceeded.

Development of a new assay, or incorporation of a chromogenic
substrate that absorbs light in a region different from that of
protein, would be advantageous for enzyme activity assay of highprotein-content

media.

Pantothenic acid and its bound forms administered orally are
converted to free pantothenic acid in the intestinal lumen of the
duodenum before entering the bloodstream (33). However, CoA and
other bound forms of pantothenate

administered intravenously led

16
to a rapid rise and then decline of CoA degradation products in the
plasma until no CoA was detectable ( 17,34 ). Apparently, the
degradative enzymes are present in blood plasma and their
activities result in free pantothenate being the only form of
degraded CoA in plasma under normal conditions (25,31 ).
Pantetheinease is usually described as an enzyme
present in tissue. One explanation of its presence in blood plasma
is for the conversion of pantetheine that has been transported out
of a cell via an ATP dependent transport system.
While investigating total blood pantothenate content,
Wittwer et al. (31) quantified human blood plasma pantetheinase
activity. A mean plasma activity of 11.2

± 2.0

µmol/min/ml

serum

in 29 fasted subjects, as determined by radiolabeled pantothenate
assay, was reported. It was determined that this plasma enzyme
activity was "comparable to activity usually added from exogenous
sources for liberation of pantothenate from whole blood" (p. 1072).
Rats fed a pantothenate-restricted

or pantothenate-deficient

diet have markedly lower serum pantothenate levels than rats fed a
normal diet (35,36). Plasma pantothenate levels may affect plasma

17

pantetheinase activity in one or more of the following ways:
i) Pantothenate inhibits pantetheinase by a product feedback
inhibition mechanism ( 5 ). A small decrease in plasma pantothenate
levels might increase pantetheinase activity.
ii) An increase in enzyme substrate might trigger release ( or
transcription/production)

of more enzyme into the bloodstream.

When substrate concentration

falls dramatically, the amount of

new enzyme released into the bloodstream may be greatly
decreased, causing an overall loss of plasma enzyme activity.
iii) Enzyme is activated by thiol compounds such as cysteine
(5). Wittwer et al. (31) reported that maximal plasma activity
rates were obtained after treatment
dithiothreitol

was omitted

with dithiothreitol;

when

from the assay, hydrolysis occurred at

5 7% the maximal rate. The plasma flux pattern of enzyme activity
may follow a similar plasma flux pattern of a thiol compound such
as cysteine.

18

REVIEW OF LITERATURE

Pantetheinase Assays

Microbial Assay
Liberation of pantothenate

was originally monitored by

microbiological assay. This assay is most successful after ion
exchange separation of pantothenate (5). This method of assay is
very time consuming and gives inconsistent results (7). Abiko's use
of this assay ( 5) did not specify whether the racemic mixture or
biologically active (D) stereoisomer of pantethine was used in the
assay.

Amine Oxidase Coupling Assay
Cavallini et al. ( 1) monitored the hydrolysis of pantetheine by
coupling the production of cysteamine to its oxidation with amine
oxidase and measuring the uptake of oxygen. Reducing compounds
were also found to activate the reaction (2), making this assay
unreliable.

19

pH-stat Titration

Assay

Dupre et al. ( 6) reported an assay utilizing pantethine as a
substrate and the quantization of hydrolysis products by a pH-stat
procedure. This requires special equipment but is much faster than
procedures using radiolabeled compounds.

Amino Acid Analysis
Orloff et al. (7) described an assay utilizing pantethine
reduced to pantetheine as a substrate. Quantization

of the n-

ethylmalei mide adduct of cysteamine was by automated ion
exchange chromatography using an amino acid analyzer.

14C Labeled Assays
Chromatographic Separation Assay. Cavallini et al. (2)
described an assay utilizing 14C DL-pantethine as substrate.
Hydrolysis products are separated by paper chromatography and the
radiolabeled products quantified. This assay requires the expensive
radiolabeled substrate. The racemic mixture was used rather than
the enzyme specific (D) form alone.

20
Electrophoretic

Separation Assay. Dupre et al. ( 4) described

an assay much like the 14C chromatographic (paper) separation
assay, but differing by an electrophoretic

separation · of hydrolysis

products. This was the fastest procedure to date but still time
consuming due to a 5-hour electrophoresis step. The racemic
mixture substrate was used.
Radiolabeled Assay . Wittwer et al. (3) described a
radiolabeled assay utilizing D-(14C]-pantethine reduced to D-(14C]pantetheine as substrate and ascending paper chromatography used
to separate resulting radiolabeled pantothenate from unhydrolyzed
radiolabeled pantetheine . While this assay is similar to the
previously mentioned paper chromatography radiolabeled assay,
labeled D-pantethine, the biologically active form is used as
enzyme substrate instead of the racemic DL-pantethine.
Pantothenate Assay. Wittwer et al. (3) described an assay
utilizing

D-(14C]-pantethine reduced to D-(14C]-pantetheine as the

enzymatic substrate. Determination of the resulting radiolabeled
pantothenate was by the radioimmunoassay of Wyse et al. (38). A
scintillation

counter and antibodies specific for pantothenate

are

21
required for this assay.

Cysteamine Assay
Wittwer et al. ( 3) described a spectrophotometric
utilizing 0-pantetheine

assay

as the substrate. The hydrolysis product,

cysteamine, is measured by the absorbance of its fluoropyruvate
adduct at 300 nm. The assay is specific for pantetheinase and
fairly

simple.

Mercaptide Assay
Wittwer et al. ( 3) described a continuous spectrophotometric
assay utilizing 0-pantetheine

as the substrate and monitoring the

absorbance of mercaptide ion at 240 nm. The mercaptide ion
concentration

increases proportionately

with hydrolysis at a

buffered pH because of a difference in pK ( -SH) between
pantetheine (9.9) and cysteamine (8.1) at 37°C. The assay is simple,
does not require radiolabeled substances or specialized equipment
other than a spectrophotometer, and due to the use of the enzyme's
native substrate, it is very specific with an apparent Km of 20 µM.

22
Pantetheine-S-Pyruvate

Assay

Dupre et al. (8) described a continuous spectrophotometric
assay using 3-pantetheine-S-pyruvate

(pantetheine-S-pyruvate)

as

a substrate for pantetheinase. The enzymatic hydrolysis of this
substrate leads to the direct formation of S-cysteamine-3pyruvate, which cyclizes in a non-rate-limiting
1 ,4-thiazin-5,6-dihydro-3-carboxylic

step to give 2H-

acid (aminoethylcysteine

ketimine), a compound exhibiting a strong absorbance at 296 nm.
The assay is specific and much more simple and rapid than other
assay procedures, but assay results give much lower activity
values (ca. 40% lower) than activity values from the mercaptide
assay which uses the enzyme's native substrate. The synthesis of
pantetheine-S-pyruvate

is quite simple but does not yield a

crystalline compound or purify it ( see synthesis scheme in methods
section). Activity values might increase if the substrate were pure
since any unreacted pantetheine in the substrate mixture would
also compete for enzymatic hydrolysis. The apparent Km value of
28 µM was similar to the reported Km from the mercaptide assay
(20 µM).
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Pantetheinase

Pantetheinase (EC 3.5.1.15) is highly specific for pantetheine
and does not hydrolyze any other carboamide bonds such as those in
~-alanylcysteamine and pantothenic acid. Pantetheinase contains
at least one thiol group at its activation site, is activated by thiol
compounds, most effectively by mercaptoethanol and dithiothreitol, and undergoes product inhibition by pantothenate ( 5 ).
In specificity studies for pantetheinase, Wittwer et al. ( 3, 3 9)
synthesized and tested several analogs of pantetheine for enzyme
specificity and concluded that the enzyme requires a coupled 0pa ntoyl-~-alanyl

moiety for significant hydrolysis to occur. This

research group further concluded that modification of the
cysteamine portion had a lesser effect on enzyme specificity, when
compared to pantetheine, after observing a 7 5 to 100% activity on
pantetheine analogs altered at the cysteamine portion.
Wittwer concluded that pantetheinase specifically engages
pantetheine-like substances on the chiral-carbon end of the
substrate, thus allowing various analogs of pantetheine to be
hydrolyzed at the amide bond specified in Fig. 3. This finding led
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Dupre et al. ( 8) to develop a continuous absorbance
spectrophotometric

assay by utilizing pantetheine-S-pyruvate

as a

substrate.
For many peptidases and proteinases, enzyme specificity
depends mostly on the substrate structure at the carboxylic side of
the bond to be split. The substrate structure at the amino side is of
much smaller influence ( 40). In artificial substrates

for color

indicator activity assays of proteases, chromogenic groups are
usually located on the amino side of the hydrolyzed bond. Groups at
the carboxylic side of this bond are selected to resemble natural
substrates to maximize enzyme specificity. Many proteases accept
esters and thioesters as substrates in addition to peptides,
frequently resulting in lower Km values and higher V values as the
reactions proceed faster.
The most commonly used chromogenic group for proteinases
is p-nitroaniline

and is typically used for the testing of trypsin

and other proteases in peptide analysis ( 41,42). While the peptidelinked p-nitroaniline
free p-nitroaniline

shows an absorption maximum at 315 nm,
has an absorption maximum at 380 nm and can
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be conveniently measured at 4 10 nm with an extinction coefficient
of 8,800 following enzymatic hydrolysis from peptide-like
molecules ( 41 ).
The ~-alanyl moiety of pantetheine (see Fig. 3) is bonded by
amide ( or peptide-like) bonds with pantetheinase hydrolyzing the
outermost amide bond. Pantetheinase must therefore act by a
mechanism similar to that of peptidases and proteinases and has in
fact been described as a thiol protease ( 43 ). It would naturally
follow that similar modifications might be made in pantetheinase
substrates for use in color indicator activity assays. Indeed, the
substrate of Dupre et al. (8 ), namely pantetheine-S-pyruvate,

is a

prime example.
With this in mind, it was hypothesized that synthesis of a
molecule with the enzyme specific pantetheine moiety coupled to a
p-nitroaniline chromogenic group, absorbing light in the visible
light region upon enzymatic hydrolysis, would result in a substrate
that could be utilized in a convenient, continuous
spectrophotometric

assay of pantetheinase activity. The enzyme

should be specific for such a substrate and have a Km similar to
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those of assays utilizing native substrates ( ca. 20 µM).
Furthermore, the assay procedure should be similar, if not
identical, to the assay described by Dupre et al. utilizing
pantetheine-S-pyruvate.

The new assay should therefore be

extremely simple and fast, yet should monitor a chromogenic
compound in the visible light region, thus avoiding interference of
protein in samples such as blood serum.
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MATERIALSAND METHODS

Chemicals

For the synthesis of pantothenate-p-nitroanilide

and assays

of pantetheinase, chemicals and solvents used were reagent grade
and obtained from the following companies: Aldrich Chemical Co.,
isopropanol, ethyl acetate, isooctane (2,2,4-trimethyl

pentane),

methylene chloride; Fisher Scientific Co., sodium hydroxide,
potassium carbonate (anhydrous), sodium chloride, carbon
tetrachloride;

J.T. Baker, methanol, hydrochloric acid; Mallinckrodt,

Inc., sodium sulfate (anhydrous), petroleum ether; Sigma Chemical
Co., Inc., ~-alanine, di-tert-butyl-pyrocarbonate,
nitroaniline,

N,N'-dicyclohexylcarbodiimide,

citric

acid, p-

tri-fluoroacetic

D( -) pantoyllactone.

Synthesis

The synthesis of pantothenate-p-nitroanilide

was

accomplished through a three-part procedure that yielded two
intermediary products and a final product, each of which was

acid,
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crystalline. Figure 4 depicts the overall reaction scheme for the
synthesis

of pantothenate-p-nitroanilide.

Preparation of t-boc-~-alanine
The synthesis of t-boc-~-alanine as previously described by
Kopelevich et al. ( 44) utilizes a reductive amination reaction
common to peptide synthesis while adding t-boc protection, which
is readily removed later by mild acid hydrolysis without cleavage
of the labile amide bond. Only minor modifications were made to
the published procedure and are outlined as follows.
First, 9.0 g of ~-alanine and 14.0 g potassium carbonate
dissolved in 100 ml water are stirred at room temperature for 30
min with 30.0 g di-tert-butyl-pyrocarbonate

that has been

previously dissolved in 100 ml isopropanol. Next, 400 ml of water
is added to the reaction mixture after which the entire solution is
washed with an equal amount of petroleum ether in a separatory
funnel and the wash discarded. The wash removes any unreacted ditert-butyl-pyrocarbonate.

Then, 60 g of citric acid is slowly added

to the solution (C0 2 is vigorously produced in this step). The citric
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Figure 4. Reaction scheme for the synthesis of pantothenatep-nitroanilide.
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acid protonates any unreacted 13-alanine, which reacts immediately
with the potassium carbonate, forming a hydrophilic product that
remains in the aqueous phase in the next step. Next, 150 g of
sodium chloride is added to the solution, which is then extracted
three times with ethyl acetate (300 ml each time) using a
separatory funnel. The salt saturates the solution and "pushes" the
t-boc-j3-alanine into the organic phase during extraction. The
combined extracts are washed with 600 ml saturated sodium
chloride solution to remove traces of citric acid without loss of
the desired t-boc-j3-alanine. The extract is then dried over
anhydrous sodium sulfate for 30 min, vacuum filtered, rotoryevaporated to an oily liquid, and allowed to recrystallize
in a 1 :1 mixture of isooctane:carbon tetra-chloride

overnight

(350-400

ml).

The fine, white crystals are then filtered, freeze-dried overnight,
and used in the second part of the synthesis.

Preparation of 13-alanyl-p-nitroanilide
The second part of the synthesis is a N,N'dicyclohexylcarbodiimide

condensation reaction in which 3.0 g t -
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boc-~-alanine,

3.91 g N,N'-dicyclohexylcarbodiimide,

and 1.1 g p-

nitroaniline are incubated in 15 ml methylene chloride at 40°C in a
closed (screw-capped) test tube for 24 hrs with shaking. The
solution is filtered and brought to a volume of 7 5 ml with
methylene chloride and washed twice with 30 ml of 3M HCI and the
wash discarded. This HCI wash removes any unreacted pnitroaniline. A 20-ml mixture of 1:1 ::TFA:CH2 Cl 2 (trifluoroacetic
acid:methylene chloride) is prepared and added to the solution with
stirring for 1 hr to remove the t-boc group from the product ( see
Fig. 4 ). Then, 40 ml of distilled water is added to the solution and
stirred. Saturated sodium carbonate (Na2 C03 ) is added ( - 18 ml)
with mixing until the aqueous phase has a pH of 5.0-6.0 and the
aqueous layer is separated off. Sodium carbonate neutralizes the
unreacted TFA and adjusts the pH so that the product is optimally
partitioned into the aqueous phase (see Table 2). The aqueous layer
is then brought to a pH of 12.0 with sodium hydroxide solution to
obtain free base product ( 1 5% NaOH is used to reduce volume
required). Since the free base product has no charge associated
with it, further

purification

from ionically charged molecules
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(salts, etc.) is easily facilitated

by extracting the solution three

times with methylene chloride. The methylene chloride extractions
are combined and rotory-evaporated

to complete dryness. A

minimal amount of warm water ( - 70°C) is added to dissolve the ~alanyl-p-NA and the solution placed at 3°C for at least 3 hrs to
crystallize.

Crystals are collected by vacuum filtration,

freeze-

dried overnight, and melting point and yield are determined. A 100%
yield for this reaction would be 3.3 g while the expected yield is
0.8 grams (24% yield). The fiberglass-like, yellow crystals have a
melting point of 146-148° C.
The yield of 24% is slightly improved (-6%) if, at the water
extraction

point, after Na2 C03 is used to raise the pH to 5-6, the

precipitate that forms between the methylene chloride and water
layers is retained by filtration,
filtered, rotary-evaporated

redissolved in methylene chloride,

to complete dryness, dissolved in dH20,

and further treated the same as ( or combined with) the normal
water extraction, that is, raise pH to 12.0 with NaOH, extract three
times with methylene chloride, and continue as previously
described.

33
Preparation

of Pantothenate-p-Nitroanilide

The third part of the synthesis consists of a condensation
reaction similar to reactions performed by Barnett and Robinson
( 45) in which the calcium and sodium salts of pantothenic acid and
several analogues are prepared by refluxing 13-alanine, or other
amino acid, with the appropriate lactone for 1 hr in methanol. The
part II product, 13-alanyl-p-nitroanilide, and an equimolar amount
of d(- )pantoyllactone,

which has been freshly resublimed to

exclude moisture, is refluxed for 1 hr in a minimal amount of
absolute methanol ( dried over anhydrous sodium sulfate and freshly
redistilled

before use) to dissolve the reactants at room

temperature. The methanol is evaporated under vacuum and the
pantothenate-p-nitroanilide

is dissolved in a minimal amount of

warm water (-60°C) and allowed to cool and crystallize at S°C
overnight.

Crystalline

Product Analysis

Each of the crystalline products obtained from the synthesis
of pantothenate-p-nitroanilide

was characterized

in the following

ways: i) a melting point was obtained on a Unimelt capillary
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melting point apparatus (Arthur H Thomas Co., Philadelphia, PA); ii)
a proton nuclear magnetic resonance (H-NMR) was obtained on a
JEOL 270 Fourier transform NMR spectrometer;

and .iii) elemental

analysis was obtained from Atlantic Microlab Inc. (Norcross, GA) as
reported.

Enzyme Purification

The pantetheinase enzyme is purified by the procedure
described by Wittwer et al. (37), with some deviations to the
published procedure, as outlined by Wittwer (39).
In this procedure, fresh pig kidneys (Thorn-Apple Valley,
Hyrum, UT) are cooled on ice and slices of cortex frozen until use.
Then, 5 50 g of semi-solid, thawed cortex are carried through the
purification, though equipment limits the scale of Steps 1 through
3 to ca. 275 g of cortex. Therefore, these steps are performed
twice per purification to provide a pooled extract from 550 g of
cortex at the end of Step 3 that is then used in the remaining
purification.
indicated.

All steps are performed at 0-4 °C unless otherwise
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Step 1: Homogenate
Four volumes of 0.02 M Tris-HCI, pH 8.2, and 27 5 g of cortex
are homogenized in a Waring blender for 4 min at high speed. The
suspension is centrifuged for 10 min at 10,000 g and the
supernatant is collected off the pelleted large particulate matter.

Step 2: Microsomal Agglutination
Microsomes in the supernatant are agglutinated at pH 4.2 by
the addition of 1 M formic acid and centrifuged for 10 min at
20,000 g. The supernatant is decanted and the pellet resuspended in
ca. 400 ml of deionized water by homogenization in a Waring
blender at high speed for 10-20 sec. The suspension is brought to
pH 5.75 with 0.5 M Tris-HCI, pH 9.0.

Step 3: Butanol Solubilization
One and a half volumes of n-butanol are added to the
microsomal suspension and the mixture is homogenized in a Waring
blender at low speed for 2 sec. The material is then centrifuged for
10 min at 10,000 g. The aqueous phase containing solubilized
enzyme is aspirated and immediately passed through a column ( 5. 5
x 65 cm) of Sephadex G-25 previously equilibrated with 0.02 M
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phosphate, pH 7.0, to remove dissolved butanol.

Step 4: Heat Treatment
The void volume eluate from Step 3 is brought to pH 5.0 with
1 M formic acid and heated in a 7 S°C water bath up to 68°C and
held at 68°C for 2 min. The suspension is rapidly cooled,
centrifuged for 10 min at 20,000 g, and the supernatant is
collected off from coagulated proteins.

Step 5: (NH4 )2 so4 Fractionation
The supernatant from Step 4 is saturated to 55% by adding
32.6 g solid (NH4 ) 2 so4 per 100 ml followed by centrifuging for 1 5
min at 20,000 g. The resulting supernatant is saturated to 70% by
adding 9.3 g (NH4 ) 2 so4 per 100 ml and centrifuged for 30 min at
20,000 g. The precipitate is dissolved in ca. 20 ml of hydrophobic
chromatography "application buffer" ( 114 g of (NH ) so added to
4 2 4
1 liter of 0.02 M phosphate, pH 7.0).

Step 6: Hydrophobic Chromatography
The protein from Step 5 is applied to a 2.5 x 23-cm column of
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Octyl-Sepharose CL-48 (Pharmacia) that had previously been
equilibrated with application buffer. The protein is washed with
application buffer at a flow rate of ca. 150 ml/hr until the A

280

of

the eluate is less than 0.05. Enzyme is eluted with a solution of
20% ethylene glycol, 80% application buffer (v/v) at the same flow
rate until the A 280 is less than 0.03. The column is regenerated by
sequentially applying one column volume each of 50 mM NaOH, 9 5%
ethanol, deionized water, and application buffer.

Step 7: Hydroxyapatite Chromatography
The enzyme eluate from Step 6 is concentrated to ca. 20 ml
by ultrafiltration

and diafiltered into 0.001 M phosphate, pH 7.0,

with an Amicon PM ultrafiltration

membrane (Lexington, MA). The

solution is applied at ca. 2 5 ml/hr to a 1. 5 x 5-cm Bio Gel HT
hydroxyapatite

column (Bio Rad, Richmond, CA) previously

equilibrated with 0.001 M phosphate, pH 7.0. Enzyme is eluted at
the same rate with 0.02 M phosphate, pH 7.0.
For specific activity

determination,

protein content of the

enzyme solution is determined by using an extinction coefficient
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as follows: El % 1cm (280 nm)= 11.3 (3 7).

Assays

Pantetheinase activity was determined by both the
mercaptide assay described by Wittwer et al. ( 3) and the
pantetheine-S-pyruvate

assay described by Dupre et al. (8), both of

which follow absorbance at appropriate wavelengths as hydrolysis
product accumulates. Synthesized pantothenate-p-nitroanilide

was

also used as a substrate in a continuous absorbance
spectrophotometric

assay monitoring accumulation of hydrolysis

product. All spectrophotometric

assays were performed on a

Gilford model 240 spectrophotometer

(Gilford Instrument

Laboratories, Inc., Oberlin, OH).

Mercaptide Assay
In a 3-ml spectrophotometer

cuvette, the enzyme is pre-

reduced by incubating 240 µI enzyme/dH 2 0 solution with 30 µI 0.5
M Tris, pH 8.5, and 30 µI of 100 mM dithioerythritol

for 20 min at

3 ?°C. The amount of enzyme depends on an estimation of activity;
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suspicion of high enzyme activity warrants inclusion of lesser
amounts of enzyme in assay. After incubation, the 300 µI of
prereduced enzyme solution is diluted with 2.69 ml of 0.05 M TrisHCI, pH 8.1, which had been deoxygenated by bubbling nitrogen gas
through the solution and prewarmed to 3 ?°C. The A

240

is followed

for 10 min or until a constant decrease with time can be
determined. Pantetheine is added ( 15 µI of 100 mM) to initiate the
reaction and the A 240 followed. The maximal ~A
per minute
240
(after linearization and before product inhibition) is proportional
to the amount of enzyme present when the rate before substrate
addition is taken as baseline.
D-Pantetheine is obtained by the reduction of D-Pantethine
by the method of Butler et al. ( 46). Pantetheine solutions are
stored under nitrogen and standardized by sulfhydryl analysis ( 4 7).
A reaction run to substrate exhaustion established a ~A 2 40
corresponding to 100% hydrolysis. This ~A 240 found with a known
amount of substrate is used in a Beer's law calculation (A=Ebc) to
calculate the extinction coefficient

for the assay.
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PE-s-pyr Assay
In a 3-ml spectrophotometer

cuvette, the enzyme is pre-

reduced by incubating 300 µI enzyme/dH

2

o solution

with 100 µI of

0.9 M mercaptoethanol and 100 µI of 0.5 M phosphate buffer, pH 8.0,
for at least 10 min at 3 ?°C. The amount of enzyme depends on an
estimation of activity; suspicion of high enzyme activity warrants
inclusion of lesser amounts of enzyme in assay. After incubation,
the 500 µI of prereduced enzyme solution is diluted with 2.4 ml of
0. 1M phosphate buffer, pH 8.0, which had been prewarmed to 37°C.
Pantetheine-S-pyruvate

is added ( 100 µI of 1 5mM) to initiate the

reaction and the A 296 followed. The maximal ~A
per minute
296
(after linearization) is proportional to the amount of enzyme
present (t = 5950).
Pantetheine-S-pyruvate

is synthesized as according to Dupre

et al. (8) by reacting 10 mM pantetheine with 20 mM bromopyruvate
in 10 ml of 0.1 M phosphate buffer, pH 8.0, at room temperature.
After 10 min, 20 mM mercaptoethanol was added. Since the product
is not crystalline, the solution was quantified for pantetheine-Spyruvate by acid hydrolysis ( 4 N HCI, 100° C, 20 min) and by
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monitoring the change in absorbance at 296 nm after neutralization
to pH=7.6.

Pantothenate-p-nitroanilide

Assay

In a 3-ml spectrophotometer

cuvette, the enzyme is

prereduced by incubating 300 µI enzyme/dH 2 0 solution with 100 µI
of 0.9 M mercaptoethanol and 100 µI of 0.5 M phosphate buffer, pH
8.0, for at least 10 min at 37°C. The amount of enzyme depends on
estimation of activity;

suspicion of high enzyme activity

inclusion of lesser amounts of enzyme in assay. After

warrants

incubation,

the 500 µI of prereduced enzyme solution is diluted with 2.4 7 ml of
0.1 M phosphate buffer, pH 8.0, which had been prewarmed to 37°C.
Pantothenate-p-nitroanilide

is added (30 µI of 12.4mM) to initiate

the reaction and the A 410 followed. The maximal ~A 41 per minute
0
(after linearization) is proportional to the amount of enzyme
present (E = 8,800) (41 ).
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Biological

Application

Assay of Pantetheinase Activity
in Rat Serum
Frozen serum samples from Sprague-Dawley rats with
varying degrees of pantothenate

nutriture were obtained from Dr.

Won Song (Michigan State University) and assayed for
pantetheinase

activity

using the pantothenate-p-nitroaniline

assay. The serum samples were from a study in which 3-week-old
Sprague-Dawley rats were assigned to one of five groups and fed
deficient and control diets ad. lib. or -pair fed for 4 and 12 weeks.
Groups were assigned experimental

semi-purified

AIN-76 diets

( 48) as follows:
Week 4: PA+ ad lib. group: 12 mg pantothenic acid/kg diet,
administered

ad. lib.

PA- ad lib. group: <0.8 mg pantothenic acid/kg diet,
administered

ad. lib.

PA+ pair fed group: 1 2 mg pantothenic acid/kg diet,
pair fed to deficient group.
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Week 12: PA+ group: 12 mg pantothenic acid/kg diet,
administered ad. lib.
PA- group: <0.8 mg pantothenic acid/kg diet, pair fed to
deficient group.
Blood samples were collected after a 24-hr fast at week 4, and an
overnight (15-16 hrs) fast at 12 weeks. Results were statistically
compared to investigate relationship between pantothenate status
and pantetheinase activity in rat blood serum by analysis of
variance (StatView 512+, Brainpower Inc., Calabasas, CA).
The pantothenate status for each serum sample was
determined by radioimmunoassay (38). The low number of samples
from the deficient group was due to many of the rats on the
pantothenate-deficient
experiment.

treatment

dying during the course of the
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RESULTS

Synthesis

Preparation of t-boc-~-alanine
The synthesis of t-boc-~-alanine (molecular weight 189.0)
yielded fine, white crystals with a melting point of 73-7 4°C in a
typical yield of 73% (ca. 14 g), which is the same as previously
reported by Kopelevich et al. ( 44). The melting point of 7 3- 7 4 °C is
also in good agreement with the published values of 7 5- 76°C.
Elemental analysis of the crystals found %: C 50.82, H 7.87, N 7.60,
O 33.74.

c18 H15 t-0 4 ; calculated%:

C 50. 78, H 7.99, N 7.99, O 33.83.

A proton nuclear magnetic resonance (H-NMR) spectrum of t-boc -~alanine in deuterated chloroform is given in Fig. 5 with peak
assignments.

Preparation of f3-alanyl-p-nitroanilide
The synthesis of J3-alanyl-p-nitroanilide

(molecular

weight

209.2) yielded fine, greenish-yellow crystals with a melting point
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of 146-149°C in a typical yield of 24% (ca. 0.8 grams). Elemental
analysis of the crystals found %: C 51.58, H 5.34, N 20.03, 0 22.94.
C9 H11 N3 o3 ; calculated%: C 51.67, H 5.30, N 20.09, O 22.94. A
proton nuclear magnetic resonance (H-NMR) spectrum of 13-alanylp-nitroanilide in deuterated water is given in Fig. 6 with peak
assignments. When looking at the H-NMR spectrum obtained from a
sample in

o2 o, it

should be noted that hydrogen atoms bound to

nitrogen and oxygen will exchange with the

o2 o solvent

and no

resonance spectrum will be seen for these hydrogen atoms.
One interesting feature that aided in purification of this
product was its ability to be selectively soluble in either organic
or aqueous solvents, depending on degree of protonation ( a factor
of pH) of the terminal nitrogen. Table 2 shows ratios of
partitioning

for f3-alanyl-p-nitroanilide

in organic and aqueous

solvents. An aqueous extraction at pH=5 extracted virtually all of
the product from the organic layer. When this aqueous extraction
was raised to a pH of 12, organic extraction performed three times
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TABLE 2. 13-alanyl-p-nitroanilide purification
solvent partitioning with pH
13-aI anyl-p-n it roan i I ide
(mmoles)
pH

1
5
7
9
10
11
12

organic*

4.03
0.27
0.40
0.98
1.30
1.67
1.57

p-nitroanilide
(mmoles)

aqueous

organic

x

0
0.17
0.18
0. 16
0.20
0. 18
0. 15

2 .82
2.98
1.97
1.74
1 .55
1 .31

by

*Organic phase is methylene chloride, aqueous phase is water.

aqueous

x

0
0.02
0 .03
0.03
0.04
0.05
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extracted

Preparation

most (-85%)

of the product out of the aqueous layer.

of Pantothenate-p-Nitroanilide

The synthesis
weight 338.0)

of pantothenate-p-nitroanilide

yielded a precipitate-like

(molecular

crystalline

product with a

melting point of 7 4-76°C with an initial yield of 14% ( ca. 0.2
grams). The yield is improved by concentrating

the crystallization

liquor. A proton nuclear magnetic resonance (H-NMR) spectrum of
pantothenate-p-nitroanilide

in deuterated water is given in Fig. 7

with peak assignments.
Stick H-NMR spectra of synthesis products as well as other
similar compounds are given in Fig. 8 to show chemical shifts of
corresponding protons.

Enzyme Purification

Enzyme purification
chromatography

resulte 'd in a hydroxyapatite

column

eluate (Step 7) enzyme preparation with a protein

content of 0.21 mg/ml, an activity of 3600 nmol/min/ml
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(pantothenate-p-nitroanilide
16,600 nmol/min/mg

assay), and a specific activity

of

protein (see Table 3). This enzyme

preparation was used exclusively in all assays ( except as noted in
the comparative assays where enzyme aliquots of varying purity
from various purification

steps were used).

Assays

Km Determination
A Lineweaver-Burk plot of initial rates with varying amounts
of enzyme (Fig. 9) reveals an apparent Km of 12.6 µM for
pantothenate-p-nitroanilide

by the purified pantetheinase enzyme.

The Lineweaver-Burke plot is quite linear with an R2 value of
0.986.

Assay Comparisons
Comparative assays for pantetheinase activity were run on
sample aliquots collected during the pantetheinase
process using the mercaptide, pantetheine-S-pyruvate,

purification
and
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Figure 9. Lineweaver-Burke plot for Km determination of
pantetheinase with pantothenate-p-nitroanilide
as
substrate. Purified enzyme ( enzyme purification Step 7
eluate) was used in the pantothenate-p-nitroanilide
assay with 12.4 mM pantothenate-p-nitroanilide
as
substrate.
Km= 12.6 µM
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pantothenate-p-nitroanilide

assays. Assay results are presented in

Table 3. The pantothenate-p-nitroanilide

assay has results similar

to the mercaptide assay while the pantetheine-S-pyruvate

assay

tended to give activity results about 66% lower than either of the
other assays.

Coefficients

of Variation

Coefficients

of variation were calculated for both the

mercaptide assay and the pantothenate-p-nitroanilide

assay by

running each assay several times using purified enzyme from Step
7 of the enzyme purification procedure and calculating the
coefficient

of variation

(activity

average/standard

deviation).

and results are given in Table 4. While the coefficient
is much lower for the pantothenate-p-nitroanilide

Data

of variation

assay than the

mercaptide assay (3.3 vs 6.1 ), it is worthwhile to note that
Wittwer et al. published a coefficient
the mercaptide assay (3).

of variance value of 3.2 for

Table 3. Assay comparisons on pantetheinase of varying purity
Stage of
purification

Activities*
PA-p-NA assay

PE-s-Pyr assay

Mercaptide assay

Proteint
(mg/ml)

(NH4) 2s:l4
fractionation

3600 (230)

1400 (92)

x

15.5

730 (1200)

320 (520)

x

0.60

2200 (2200)

1100 ( 1100)

x

1.0

Hydrophobic
chromatography
Ultra filtration

Hydroxyapatite
chromatography

3600

(16,600)

1200

(5600)

3600

(16,500)

0 .22

* Activity given in terms of nmol/min/ml
specific activity (in parenthesis) in terms of nmol/min/mg protein.
t Protein (mg/ml)=[A 280 *dilution factor]/1.13 (References 37 & 39).
Note: Enzyme samples are from the pantetheinase purification with the ( NH4 ) 2 S) 4 fractionation being
from Step 5, the hydrophobic separation from Step 6, the ultrafiltration from the first part of Step 7,
and the hydroxyapatite chromatography sample being the final purified enzyme.

tn
tn
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Table 4. Coefficien~ of variation of two
pantetheinase assays

Run#

Activity (nmol/min/ml)
pantothenate-pMercaptide assay nitroanilide assay

1
2
3
4
5
6
7
8
9
10

3700
4000
3700
3500
3800
3900
3500
3500
3300
3600

3600
3400
3700
3800
3800
3800
3700
3500
3700
3600

average
st . deviation
coeff. of variation

3650
224.1
6.1%

3665
121 .5
3.3%
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Biological

Application

Rat serum samples were assayed for pantetheinase activity
using the pantothenate-p-nitroanilide

assay. Data and results are

given in Table 5. Week 4 serum pantetheinase activities were
significantly different between the PA+ ad lib (average ± st. dev.

=

8.8 ± 1.5) and the PA- ad lib group (ave.± st. dev. = 16 ± 4.2) as
well as the PA- ad lib group and the PA+ pair fed group (ave. ± st.
dev. = 6.3 ± 0. 7) (p=0.0022 and p=0.0005, respectively) by one-way
analysis of variance. The PA- ad lib group had higher enzyme
activities

than the control groups. Serum pantothenate

also significantly

different

(p<0.02 and p<0.001,

levels were

respectively)

with

the deficient group having lower values (ave. ± st. dev. PA- ad lib =
0.14 ± 0.04 vs. PA+ ad lib = 0.52 ± 0.22 and PA+ pair fed = 0.54 ±
0. 15 ). The week 12 pantothenate-deficient
significantly

different

pantetheinase

group did not have a

activity

than the

pantothenate-enriched group (ave. ± st. dev = 7.9 ± 2.0 and 10.5 ±
4. 7, respectively; p=O. 12) by one-way analysis of variance. Week 1 2
PA- group serum pantothenate

values were significantly

lower

than the week 12 PA+ control group (ave. ± st. dev. = 0. 10 ± 0.05 and
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0.51 ± 0.20, respectively; p=0.001 ). Figure 10 shows a plot of
serum pantothenate

values versus serum pantetheinase activity.
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Table 5. Pantetheinase activity for serum samples of rats with
varying pantothenic acid nutriture
Activity(nmol/min/ml)
Serum pantothenate (nmol/ml)
6.8
0.68
9.4
0.40
7.8
"
" 3
0.36
" 4
9.6
0.26
10.9
5
0.40
7.4
p=.0022
6
0.87 p=.0207
7
9.4
0.64
ave.± st. dev. = 0.52 ± 0.22
ave. ± st. dev. = 8.8 ± 1.5
4 wk. PA- ad lib. 1
20.8
0 . 13
"
" 2
12.8
0 . 18
"
" 3
14.9
0.11
ave. = 16.2 ± 4.2
ave. = 0. 14 ± 0.04
4 wk. PA+ pair fed 1
6.0
0.36
"
2
6.7
p= .0005
0.56
p=.0029
6.9
0.76
"
3
0.47
5.9
"
4
"
6.9
5
0.63
"
"
6
5. 1
0.43
"
ave. = 0.54 ± 0.15
ave. = 6.3 ± 0.7
0.21
7.2
12 wk. PA+
1
6.4
0 .38
2
4 .8
0.49
3
"
9.4
"
4
0.81
7.7
5
0.46
"
0.48
5.4
6
"
0.58
9.9
"
7
0.72
6.2
8
0.40
10.9
"
9
0.36
7.2
"
10
0.86
p=.0012
9.5
p=.1174
1
1
"
0.36
9.6
12
ave.= 0.51 ± 0.20
ave. = 7.9 ± 2.0
0.13
1 4. 1
12 wk. PA- 1
0.15
2
14.4
"
0.06
"
4.6
3
0.05
"
4
9.0
ave.= 10.5 ± 4.7
ave.= 0.1 O ± 0.05
* All samples were collected after a 24-hr fast. Wk 4 PA+ ad lib. group was fed a
control diet with 12 mg pantothenate/kg diet ad lib. Wk 4 PA- group was fed a
deficient diet of <0.8 mg pantothenate/kg diet. Wk 4 PA+ pair fed group was fed the
control diet, pair fed to corresponding deficient rats. 12-wk group samples were
collected at end of the 12th week of the experiment, PA+ group having been fed the
control diet and PA- group fed the deficient diet. p-values compare controls to its
deficient group (ANOVA).
*Group & Rat #
4 wk. PA+ ad lib. 1
"
" 2
II
II

II

II

II

II

II

II
II

II

II

II

II
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DISCUSSION

Synthesis

The main objective

for the pantothenate-p-nitroanilide

synthesis project was to obtain a pure crystalline product,
specific for the enzyme pantetheinase, which would absorb light in
the visible light region upon enzymatic hydrolysis. The result
obtained was synthesis of a pure substrate compound with a sharp
melting point, containing the most widely used chromogenic group
in peptide chemistry,

namely p-nitroaniline.

Synthesis of the pantothenate-p-nitroanilide
simple and straightforward
results in sufficient

was fairly

as presented here. The synthesis

substrate

mg pantothenate-p-nitroanilide,

for approximately

1500 assays (200

MW=338.0, yields 47.7 ml of 12.4

mM substrate solution).
The proton nuclear magnetic resonance spectrum for the final
product pantothenate-p-nitroanilide
stereocenter

is shown in Fig. 7. The chiral

of the molecule is responsible for the a-b splitting

patterns seen at 0. 78 ppm and at 3.21 ppm. The unusual nine-peak
multiplet splitting pattern at 3.43 ppm is harder to explain but
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may be due to a cis-trans amide bond interaction. Comparative HNMR spectra in Fig. 8 are from Wittwer (39), and demonstrate in
particular how addition of a group on the amino end of the
pantothenate moiety leads to resolution of superimposed peaks.
Pantothenate-p-nitroanilide

is a crystalline product. As such,

the compound should have a longer shelf-storage life than other
substrates of spectrophotometric

pantetheinase assays which are

not crystalline compounds, namely, pantetheine and pantetheine-Spyruvate. Furthermore, pure substrat _e solutions can be prepared
from the pure pantothenate-p-nitroanilide

crystals, a trait that

has not been reported for the other spectrophotometric

assays

using impure, noncrystalline substrate compounds.

Enzyme Purification

The enzyme obtained from the purification process of
Wittwer

et al. (37,39) had an activity of 3600 nmol of

pantothenate liberated/min/ml

as determined by both the

mercaptide assay and the pantothenate-p-nitroanilide
specific activity

of 16,600 nmol/min/ml

assay, a

by the pantothenate-p-

63
nitroanilide assay (sp. act.

=

16,500 nmol/min/ml

by the

mercaptide assay), and a protein content of 0.22 mg protein/ml.
This preparation of pantetheinase would appear to be of a higher
purity than has been previously reported. Wittwer et al. reported a
pantetheinase preparation having a protein content of 4.0 mg/ml
and a specific activity of 14,000 nmol/min/mg

protein (37). The

enzyme preparation reported in this study has an 18% higher
specific activity

than that previously reported.

Assays

The pantothenate-p-nitroanilide

proved to be a very good

substrate for the enzyme pantetheinase, resulting in apparent
activity values comparable to those obtained from the mercaptide
assay, which uses the enzyme's physiological substrate,
pantetheine.
The pantothenate-p-nitroanilide
of the pantetheine-S-pyruvate

assay has all the advantages

assay, namely, speed and simplicity,

but with a pure substrate, resulting in activity

values identical to

the mercaptide assay. The pantetheine-S-pyruvate

assay
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consistently

gave activity values that were only one-third to one-

half those obtained from either the mercaptide assay or the
pantothenate-p-nitroanilide

assay.

The ability to measure activity

in high-protein-content

media such as blood serum is perhaps the greatest asset of this
assay, a trait other continuous spectrophotometric

assays have not

been capable of for this enzyme. This assay provides a faster and
simpler method of determining pantetheinase activity

in blood

serum than any method reported to date. The advantages the
pantothenate-p-nitroanilide

assay provides over other assays

should be found useful in furthering study of pantothenate
homeostasis.

Biological

Application

While there was not a great number of serum pantothenate
deficient samples available, the week 4 samples tested had a
significantly

higher pantetheinase

activity

than the rat serum

samples which were not pantothenate deficient (see Table S). Week
12 samples might have been similar but for the exception of two
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deficient samples which were grossly pantothenate

deficient;

these two samples had pantetheinase activities similar to the
normal serum pantothenate samples.
Pantetheinase appears susceptible to product feedback
inhibition by pantothenate ( 5 ). This might explain the increased
activity

of the mildly (but still significantly)

deficient samples.

As substrate levels decline, the activity of the enzyme increases,
presumably so as to convert any substrate encountered. The amount
of enzyme in the blood plasma may be regulated in such a way that
when substrate

levels increase dramatically, more enzyme is

introduced into circulation. Conversely, with a dramatic decrease
in substrate concentration, much less or no new enzyme is
introduced, leading to a natural reduction of enzyme as it is
cleared from the system. The two samples from week 12 with
grossly low serum pantothenate

levels were approaching serum

levels associated with immediate death. These values may have
been so low that despite being more "active" due to lack of product
inhibition,

the amount of plasma enzyme may have already been

greatly reduced. However, half-life studies of pantetheinase in
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blood serum were not found in the literature. Obviously, more
knowledge about pantetheinase and its regulation in blood serum is
required before any definite conclusions might be made.
The two samples from week 12 with grossly low
pantothenate

levels had enzyme activities similar to the control

group values, suggesting that other methods may be more suitable
for severe pantothenate deficiency monitoring. However, the
pantothenate -p-nitroanilide assay might be of use in detecting
mild (but significant)

pantothenate

deficiencies as plasma

pantetheinase activity seems to increase under mildly deficient
conditions (see Fig. 10).
More studies should be conducted to further investigate how
pantetheinase activity varies with pantothenate

status and

nutriture. How serum enzyme activity may vary under an ingested
meal load, intramuscular pantetheine injection, or injection into a
vein may be of particular interest.
assay for pantetheinase activity
in studies such as this.

The pantothenate-p-nitroanilide
is particularly

well suited for use
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Summary

Pantothenate-p-nitroanilide

was synthesized for use as a

substrate in a simple, continuous spectrophotometric

assay of

pantetheinase activity. The substrate compound is crystalline and
economical as 200 mg of crystalline pantothenate-p-nitroaniline
will yield approximately 1 500 assays in a 12.4 mM substrate
solution. The substrate is suitable for assaying pantetheinase in
high-protein-content

media such as blood serum as the enzymatic

hydrolysis product, p-nitroaniline,

absorbs light in the visible light

region where there is little or no absorbing inhibition from serum
proteins.
This pantothenate-p-nitroanilide

assay provides a faster and

simpler method of determining pantetheinase activity in blood
serum than any method reported to date. Pantetheinase activity
results obtained from the assay may also prove to be a more
sensitive indicator of pantothenate

deficiency than current

methods. The advantages the pantothenate-p-nitroanilide

assay

provides over other assays will perhaps prove to be an incentive
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for further study of the role pantetheinase may play in
pantothenate

homeostasis.
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